06

The field of cellular and gene therapy is rapidly growing and starting to become one of the most potent therapy next to pharmaceuticals. Since last year’s approval of Chimeric Antigen Receptor T (CAR-T) cells by FDA, cancer therapy through immune modification has been becoming a highlight. Same holds true in the area of mesenchymal stem cell (MSC) biology and therapy, which highlighting the new development of exosomes and gene modified cells.

International Society for Cellular Therapy (ISCT) is a global society focused on pre-clinical and translational aspects of developing cell-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. This year’s ISCT Annual Meeting was held on 02 - 05 May 2018 in Montreal, Canada. This event successfully gathered 1062 international delegates representing 51 countries. Two delegates from SCI, Christine Ayu, Apt. and Dilafitria Fauza, M.Sc, attended the meeting and had the opportunity to share their work on MSC research through poster presentation entitled
Hypoxia Increases VEGF Secretion in Multiple Sources of Mesenchymal Stem Cells (presented by Ms. Ayu) and Mesenchymal Stem Cell-derived VEGF Improves Characteristics of Endothelial Progenitor Cells (presented by Ms. Fauza). Both of the works were conducted together with other SCI researchers, Yuyus Kusnadi, Ph.D and Felicia Bianca Tjahjadi, B.Sc.

ISCT 2018 Annual Meeting discussed wide range of cellular therapy updates, which mainly focused on CAR-T cells therapy regulatory and its related issues worldwide. There were also hot topic session forums discussing T-cell treatment regulatory of autoimmunity, immunologic sculpting of Hematopoietic stem cell transplantation (HSCT), and grafts, as well as the ever fertile area of MSC therapy and the exciting new application of exosomes, genetically modified immune cells, and the updates on clinical application of Natural Killer (NK) cells therapy. ISCT Annual Meeting has been a great opportunity for SCI to expand global knowledge regarding cellular therapy in both area of stem cell and cancer. SCI participation in this international renowned event not only enrich our institution with new insights and perspectives which is highly beneficial to our future research, but also gain global recognition as an institution that mainly focus on biopharmaceuticals development.



Figure 1. Ms. Fauza (on the left) and Ms. Ayu (on the right) presented their poster at
ISCT Annual Meeting 2018 at Montreal, Canada.



Post Rating

Comments

There are currently no comments, be the first to post one.

Post Comment

Only registered users may post comments.

News & Events

SCAN

Events

SCI - Events

Stem Cell News

Cell Therapy News

Cancer News

Internship Program